CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-15 | Payson Norman Director | Sale | −900 | $43.58 | $39K | 365,086 |
| 2022-09-14 | Payson Norman Director | Sale | −6,618 | $41.71 | $276K | 371,704 |
| 2022-09-09 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −112 | $41.85 | $5K | 79,179 |
| 2022-09-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +3,812 | $3.95 | $15K | 328,728 |
| 2022-09-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −2,930 | $43.02 | $126K | 325,798 |
| 2022-09-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −882 | $43.30 | $38K | 324,916 |
| 2022-09-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −732 | $43.02 | $31K | 122,348 |
| 2022-09-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −221 | $43.30 | $10K | 122,127 |
| 2022-09-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Option (Right to Buy) | −3,812 | 1,515,555 | ||
| 2022-09-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +32,000 | $3.95 | $126K | 356,916 |
| 2022-09-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −2,960 | $40.22 | $119K | 353,956 |
| 2022-09-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −16,457 | $41.54 | $684K | 337,499 |
| 2022-09-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −12,583 | $42.04 | $529K | 324,916 |
| 2022-09-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −740 | $40.22 | $30K | 130,340 |
| 2022-09-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −4,115 | $41.54 | $171K | 126,225 |
| 2022-09-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −3,145 | $42.04 | $132K | 123,080 |
| 2022-09-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Option (Right to Buy) | −32,000 | 1,519,367 | ||
| 2022-09-08 | Schlanger David J Executive Chairman | Exercise or conversion | +14,854 | $0.91 | $14K | 97,402 |
| 2022-09-08 | Schlanger David J Executive Chairman | Sale | −1,500 | $40.27 | $60K | 95,902 |
| 2022-09-08 | Schlanger David J Executive Chairman | Sale | −9,954 | $41.61 | $414K | 85,948 |
Page 43 of 77 · 1,524 trades